V005-1571 Screening compound: 6-[(4-benzylpiperazin-1-yl)methyl]-2-[4-(4-butylbenzoyl)piperazin-1-yl]-3,4-dihydropyrimidin-4-one

V005-1571 Screening compound: 6-[(4-benzylpiperazin-1-yl)methyl]-2-[4-(4-butylbenzoyl)piperazin-1-yl]-3,4-dihydropyrimidin-4-one
V005-1571 Screening compound: 6-[(4-benzylpiperazin-1-yl)methyl]-2-[4-(4-butylbenzoyl)piperazin-1-yl]-3,4-dihydropyrimidin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V005-1571
6-[(4-benzylpiperazin-1-yl)methyl]-2-[4-(4-butylbenzoyl)piperazin-1-yl]-3,4-dihydropyrimidin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V005-1571

Molecular Formula

C31H40N6O2 (C31 H40 N6 O2)

Compound Name

6-[(4-benzylpiperazin-1-yl)methyl]-2-[4-(4-butylbenzoyl)piperazin-1-yl]-3,4-dihydropyrimidin-4-one

IUPAC name

6-[(4-benzylpiperazin-1-yl)methyl]-2-[4-(4-butylbenzoyl)piperazin-1-yl]-34-dihydropyrimidin-4-one

SMILES

CCCCc(cc1)ccc1C(N(CC1)CCN1C(N1)=NC(CN2CCN(Cc3ccccc3)CC2)=CC1=O)=O

InChI

InChI=1S/C31H40N6O2/c1-2-3-7-25-10-12-27(13-11-25)30(39)36-18-20-37(21-19-36)31-32-28(22-29(38)33-31)24-35-16-14-34(15-17-35)23-26-8-5-4-6-9-26/h4-6,8-13,22H,2-3,7,14-21,23-24H2,1H3,(H,32,33,38)

InChI Key

ULVRDICOQJENIK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19859557

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

528.7

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.594

Distribution Coefficient, logD

1.807

Water Solubility, LogSw

-3.66

Polar Surface Area

62.092

Acid Dissociation Constant (pKa)

8.87

Base Dissociation Constant (pKb)

8.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.20

V005-1571 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V005-1571 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V005-1571?
Check Price and Availability of V005-1571, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V005-1571 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V005-1571
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V005-1571
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V005-1571 available by request